Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Vinorelbine MeSH Descriptor Data 2025


MeSH Heading
Vinorelbine
Tree Number(s)
D03.132.436.681.827.915
D03.633.100.473.402.681.827.915
D03.633.100.496.500.500.681.827.915
Unique ID
D000077235
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077235
Scope Note
A vinca alkaloid related to VINBLASTINE that is used as a first-line treatment for NON-SMALL CELL LUNG CANCER, or for advanced or metastatic BREAST CANCER refractory to treatment with ANTHRACYCLINES.
Entry Term(s)
5'-Nor-anhydrovinblastine
KW 2307
KW-2307
Navelbine
Vinorelbine Tartrate
Pharm Action
Antineoplastic Agents, Phytogenic
Tubulin Modulators
Registry Numbers
Q6C979R91Y
0
253GQW851Q
Related Numbers
253GQW851Q
71486-22-1
CAS Type 1 Name
C'-Norvincaleukoblastine, 3',4'-didehydro-4'-deoxy-
Public MeSH Note
2019; VINORELBINE was indexed under VINBLASTINE 1981-2018
History Note
2019 (1981)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2020/05/27
Vinorelbine Preferred
KW 2307 Narrower
Navelbine Narrower
Vinorelbine Tartrate Narrower
page delivered in 0.132s